Moderate

Lactational mastitis & breast abscess

Inflammation/infection of the breast in a breastfeeding woman; usually from milk stasis +/- Staphylococcus aureus. Early milk drainage prevents progression; fluctuant/non-resolving = abscess needing drainage. DRAFT for clinician review. · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Lactational mastitis is a painful, red, warm, swollen segment of breast in a breastfeeding woman, often with systemic flu-like symptoms, caused by milk stasis that may progress to bacterial infection (commonly Staphylococcus aureus, including MRSA in some settings). The cornerstone of treatment is effective and continued milk removal (keep breastfeeding/expressing) — most early inflammatory mastitis settles with conservative measures within 24-48 h. Antibiotics are added if systemically unwell, a nipple fissure is infected, cultured infection, or no improvement after effective milk drainage. A fluctuant mass or failure to respond suggests a breast abscess requiring ultrasound and needle aspiration or incision & drainage. Breastfeeding should continue.

Red flags

  • Systemic sepsis: high fever, rigors, tachycardia, hypotension (admit for IV antibiotics)
  • Fluctuant mass / swinging fever / no response to antibiotics = breast abscess
  • Erythema persisting despite adequate treatment = exclude inflammatory breast cancer
  • Rapidly spreading cellulitis, severe pain out of proportion (necrotising infection — rare)
  • Recurrent mastitis in the same location
  • Severe nipple damage with signs of deep infection

Assessment

Differential diagnosis

  • Simple engorgement / blocked duct (no systemic illness)
  • Non-lactational/periductal mastitis
  • Breast abscess (fluctuant, non-resolving)
  • Inflammatory breast cancer (consider if not resolving with treatment — persistent erythema/peau d'orange)
  • Candidal nipple/breast infection (burning pain, often bilateral)
  • Cellulitis of chest wall
  • Galactocele

Investigations

  • Mostly clinical diagnosis; assess for systemic sepsis (temperature, HR, BP)
  • Breast milk culture if severe, recurrent, hospital-acquired, or not responding (guides antibiotics; MRSA)
  • Breast ultrasound if abscess suspected (fluctuant mass, swinging fever, no response to antibiotics)
  • FBC/CRP and blood cultures only if systemically septic
  • Swab any infected nipple fissure
  • If erythema persists despite adequate treatment, refer to exclude inflammatory breast cancer

Management

  • First-line: effective milk removal — continue breastfeeding or express from the affected breast frequently; ensure good attachment/positioning (involve infant-feeding support)
  • Supportive care: analgesia/anti-inflammatory (ibuprofen, paracetamol), warm compress before feeds, cold packs after for comfort, rest, hydration
  • Reassess after 12-24 h of effective drainage; start antibiotics if systemically unwell, infected nipple fissure, positive culture, or no improvement despite good milk removal
  • Antibiotics should cover Staphylococcus aureus (flucloxacillin first-line); use breastfeeding-compatible agents and continue feeding
  • If fluctuant mass or no response to antibiotics -> ultrasound; treat abscess by ultrasound-guided needle aspiration (repeat as needed) or incision & drainage if large/not resolving
  • Advise continuing breastfeeding from both breasts (safe and aids resolution); if too painful, express affected side
  • Safety-net: return if worsening, systemically unwell, or not improving in 48 h (consider abscess, resistant organism, or rarely inflammatory cancer)
  • Address recurrence: feeding technique, avoid pressure/tight bras, treat nipple damage/candida

Drugs & doses

Flucloxacillin 500 mg PO four times daily for 10-14 days (first-line; covers S. aureus; breastfeeding-compatible) [verify local]
Penicillin allergy: erythromycin 250-500 mg PO four times daily OR clarithromycin 500 mg PO twice daily for 10-14 days [verify local]
Consider co-amoxiclav 625 mg PO three times daily if mixed flora/periductal [verify local]
MRSA risk/confirmed: co-trimoxazole or clindamycin per sensitivities (co-trimoxazole caution in neonatal jaundice/G6PD/<2 months) [verify local]
Ibuprofen 400 mg PO three times daily + paracetamol 1 g PO four times daily for pain/inflammation (both breastfeeding-compatible)
Severe/septic: IV flucloxacillin 1-2 g IV four times daily (admit) [verify local]
Nipple candidiasis: topical miconazole to nipple + oral fluconazole/nystatin for infant if indicated [verify local]

Disposition

Most managed as outpatients with milk drainage +/- oral antibiotics and feeding support; review at 48 h. Admit for IV antibiotics if systemically septic. Refer for ultrasound and drainage if abscess. Breast/surgical referral if non-resolving or suspicion of malignancy. Provide lactation support to prevent recurrence and preserve breastfeeding.

Complications & pitfalls

  • Breast abscess
  • Sepsis (rare)
  • Premature cessation of breastfeeding
  • Recurrent mastitis; milk fistula after drainage
  • Scarring; rarely functional impact
  • Missed inflammatory breast cancer if persistent erythema not investigated

Exam pearls

  • Milk removal is the treatment — keep breastfeeding/expressing; stopping makes it worse.
  • Not every mastitis needs antibiotics: early inflammatory mastitis often settles with drainage in 24-48 h.
  • Flucloxacillin is first-line (covers S. aureus) and is safe in breastfeeding.
  • Fluctuant mass or failure to respond = ultrasound for abscess; aspirate rather than always incise.
  • Breastfeeding during mastitis/abscess (even from the affected side) is safe for the baby.
  • Persistent, non-resolving breast erythema must prompt thought of inflammatory breast cancer.

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.